Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
23
|
pubmed:dateCreated |
1989-9-11
|
pubmed:abstractText |
In this study, we examined whether and how the cellular activity of interleukin-2 (IL-2) is affected by glutathione (GSH), an important tripeptide existing in most cells. Cell culture and thymidine incorporation assay showed that addition of GSH enhanced the effect of IL-2 on the proliferation and thymidine incorporation of IL-2-dependent cytotoxic T-cells such as CTLL-2 and CT-4R. Treatment of the cells with GSH resulted in a 2-fold increase in the amount of IL-2 bound to the cells and a rapid internalization of the bound IL-2. In addition, the degradation of IL-2 in the cells was enhanced by GSH treatment. These effects of GSH were accompanied by an increase in the intracellular GSH level. L-Buthionine-(S,R)-sulfoximine, an inhibitor of de novo GSH synthesis, blunted the increase of intracellular GSH level and modulated the effect of GSH on IL-2 activity. These results suggest that GSH regulates the binding, internalization, degradation, and T-cell proliferative activity of IL-2; alterations of cellular GSH concentration may thus affect the growth and replication of IL-2-sensitive cytotoxic T-cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites,
http://linkedlifedata.com/resource/pubmed/chemical/Buthionine Sulfoximine,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Methionine Sulfoximine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Thymidine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
264
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
13519-23
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2788161-Animals,
pubmed-meshheading:2788161-Antimetabolites,
pubmed-meshheading:2788161-Buthionine Sulfoximine,
pubmed-meshheading:2788161-Cell Line,
pubmed-meshheading:2788161-DNA Replication,
pubmed-meshheading:2788161-Glutathione,
pubmed-meshheading:2788161-Interleukin-2,
pubmed-meshheading:2788161-Kinetics,
pubmed-meshheading:2788161-Methionine Sulfoximine,
pubmed-meshheading:2788161-Receptors, Interleukin-2,
pubmed-meshheading:2788161-Recombinant Proteins,
pubmed-meshheading:2788161-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:2788161-Thymidine
|
pubmed:year |
1989
|
pubmed:articleTitle |
Glutathione regulates interleukin-2 activity on cytotoxic T-cells.
|
pubmed:affiliation |
Division of Blood and Blood Products, Food and Drug Administration, Bethesda, Maryland.
|
pubmed:publicationType |
Journal Article
|